Company: Haisco Pharmaceutical Group Company Limited

Bloomberg ticker: 002653 SZ

Market cap: US$7,253m

Background: Haisco Pharmaceutical Group Company Limited focuses on researching, developing, and producing new drugs, particularly in therapeutic areas like anesthesia, parenteral nutrition, and liver disease. Operating mainly in China, it serves hospitals and pharmacies, with a strong presence in the Chinese market and a growing focus on global innovation.
 

World Class Benchmarking of Haisco Pharmaceutical Group
 

(Click on image to enlarge)

• Profitable Growth rank of 5 was up compared to the prior period’s 7th rank
• This is average performance compared to 360 medium Health Care companies worldwide
• Profitability rank of 5 was better than its Growth rank of 7
• Profitability rank of 5 was up compared to the prior period’s 6th rank
• This is average performance compared to peers
• Growth rank of 7 was up compared to the prior period’s 8th rank
• This is below average performance compared to peers

More By This Author:

Stock Analysis: Bangkok Chain Hospital
Stock Analysis: NH Foods
Stock Analysis: Minor International